Allistar Peters

Finding the balance of empathy and professionalism is a skill that not enough of us recognize as essential, and even fewer seek to teach.

Attempting to engage on an intellectual level about the heady concept of brain death while in the throes of bereavement can often lead to mistrust and confusion.

Although several studies have established the use of endovascular therapy with stent retrievers for selected acute stroke as standard of care, best practices surrounding the best sedation strategy remain unclear.

Results from a secondary analysis of the ENCHANTED trial add to a pile of weak data that likely will not affect clinical practice.

Despite disappointing results, tenecteplase’s story in stroke treatment might not be over.

Recent research found benefits in outcome outweighed any increase in hemorrhagic complications in patients with large infarcts.

Although the study did not demonstrate efficacy of glyburide, differences were seen in the amount midline shift at 3-4 days.

The greatest hurdle in developing effective treatments for TBI lies in the varied and dynamic pathophysiology and incomplete understanding of factors leading to poor outcome.

Despite 3 large randomized trials and updated guidelines, the question of PFO closure remains a complex entity.

A joint medical and surgical approach may ensure the best outcome.

AAN GDDI subcommittee seemed less than supportive of the use of etanercept in post-stroke disability.

The idea of low-dose tPA will likely not be abandoned despite recent findings.

Ticagrelor may have an opportunity to shine in patients already on aspirin or clopidogrel.